A study in the Journal of the American Medical Association ( JAMA ) found that patients with type 2 diabetes who had been taking the GLP-1 agonists Bydureon (exenatide...
Research
The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
49 readers recommended
Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.
JDRF and PureTech Launch Groundbreaking New Fund, T1D Innovations, Designed to Fund Type 1 Therapies
24 readers recommended
On Tuesday October 15, JDRF and PureTech announced the launch of T1D Innovations, an exciting new fund that aims to supply crucial funding for the development of type 1...
41 readers recommended
How you can help to prevent type 1 diabetes…
27 readers recommended
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
51 readers recommended
Can more type 2 therapies be used for type 1 diabetes?
26 readers recommended
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
61 readers recommended
Kelly’s transformative experience wearing an artificial pancreas for five days.
35 readers recommended
On November 1, Dr. Ed Damiano presented results from the Beacon Hill study and Summer Camp study of the bionic pancreas at Carb DM ’s Second Anniversary. For more...
Lilly and T1D Exchange Announce Research Collaboration to Support People Living With Type 1 Diabetes
44 readers recommended
On April 9, Lilly and T1D Exchange announced a five-year research collaboration on projects designed to improve the health and wellbeing of people with type 1 diabetes...
24 readers recommended
In May, Lexicon announced its results of LX4211, an SGLT-1/SGLT-2 inhibitor. The phase 2 trial finished its open-label, pioneer section, which showed a decrease in...
45 readers recommended
Halozyme announced recently that Yale researchers have started a 20-patient artificial pancreas study (which is still recruiting) that will test the ability of...
26 readers recommended
On April 24, Hyperion Therapeutics announced that it would acquire Andromeda Biotech. Andromeda is focused on the development of a first-in-class immune therapy for new...
35 readers recommended
TrialNet is bringing their services online, making it easier for people to be screened for type 1 diabetes. Family members of those with type 1 diabetes can answer an...
28 readers recommended
On November 4, JDRF announced a partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) to support what they call promising diabetes research in collaboration...
79 readers recommended
At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.
31 readers recommended
The National Institutes of Health (NIH) recently announced it will provide millions of dollars in funding for the first large-scale clinical trial to determine whether...
84 readers recommended
A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.
45 readers recommended
You call that an artificial pancreas? The pathway to closed loop system.
34 readers recommended
On July 10, the JDRF and 161 delegates for the Children’s Congress traveled to Capitol Hill inWashington, D.C. to call for support of type 1 diabetes research funding...